复杂的,多膜性风湿性心脏病的外科再干预
Kathleen R Khan1, Christopher R Burke2, Jill M Steiner1
1Division of Cardiology, Department of Surgery, University of Washington School of Medicine, Seattle, Washington, USA.
JACC. Case reports
|October 24, 2025
概括
多门干预是复杂的,特别是在之前的手术后. 精心规划和共享决策对于管理复杂的心脏门疾病病例至关重要.
科学领域:
- 心脏病学 心脏病学
- 心脏外科手术 心脏外科手术
- 医疗成像医学成像
背景情况:
- 多门干预存在重大风险,特别是在有先前门手术史的患者中.
- 风湿性心脏病可能导致复杂的多膜病理需要干预.
研究的目的:
- 为了说明管理复杂的多膜疾病病例需要重新干预的挑战和考虑.
- 突出多学科规划和共享决策在高风险心脏手术中的重要性.
主要方法:
- 一名52岁的女性患者患有风湿性心脏病和严重的多功能障碍,接受了全面的多模式成像.
- 外科干预包括生物假肢本塔尔和指挥手术程序与三管修复.
- 由于大动脉假体尺寸小,透过导管的选择受到限制.
主要成果:
- 患者呈现出严重的大动脉, mitra 和三管回/缩小.
- 尽管手术风险增加,但患者成功接受了复杂的多门手术.
- 手术后恢复因右心室功能障碍而复杂,但最终导致出院.
结论:
- 复杂的多门干预需要细致的规划,包括心脏门团队的协作和共享决策.
- 在多膜疾病中,没有一种适合所有人的方法来重新干预;患者的价值至关重要.
- 有效的沟通和多学科的投入对于导航具有挑战性的心脏手术病例至关重要.
相关概念视频
Mitral Stenosis III: Medical Management
245
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
245
Rheumatic Heart Disease III: Medical Management
282
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
282
Mitral Regurgitation III: Medical Management
274
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
274
Aortic Regurgitation III: Medical Management
392
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
392
Mitral Regurgitation IV: Nursing Management
303
Mitral regurgitation (MR) is a condition where the mitral valve does not close properly, leading to the backward flow of blood from the left ventricle into the left atrium during systole. This condition can arise from various causes, including rheumatic fever, infective endocarditis, or degenerative valve disease. Effective nursing management is crucial to optimizing patient outcomes and involves comprehensive assessment and targeted interventions.Comprehensive Patient AssessmentA detailed...
303
Endocarditis III: Medical Management
210
Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
210


